Stephen W. Macmahon
#105,327
Most Influential Person Now
Stephen W. Macmahon's AcademicInfluence.com Rankings
Stephen W. Macmahonmedical Degrees
Medical
#1306
World Rank
#1632
Historical Rank
Cardiology
#90
World Rank
#92
Historical Rank

Stephen W. Macmahonphilosophy Degrees
Philosophy
#4235
World Rank
#6682
Historical Rank
Logic
#1742
World Rank
#2578
Historical Rank

Download Badge
Medical Philosophy
Stephen W. Macmahon's Degrees
- PhD Biochemistry Stanford University
Why Is Stephen W. Macmahon Influential?
(Suggest an Edit or Addition)Stephen W. Macmahon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. (1998) (5391)
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
- Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias (1990) (4608)
- Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context (1990) (4606)
- Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack (2001) (2412)
- Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials (2000) (2202)
- Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials (2000) (1778)
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction (1995) (1755)
- Severe hypoglycemia and risks of vascular events and death. (2010) (1317)
- Interpretation of the evidence for the efficacy and safety of statin therapy (2016) (1290)
- Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000) (962)
- Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. (2003) (930)
- ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION (1992) (920)
- Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
- Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis (2016) (826)
- Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. (2005) (810)
- Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials (2008) (686)
- Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. (1994) (607)
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment (2013) (605)
- Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. (1991) (585)
- 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. (1999) (557)
- Blood pressure, cholesterol, and stroke in eastern Asia (1998) (553)
- Blood pressure and cardiovascular disease in the Asia Pacific region (2003) (550)
- Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
- Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data (2014) (449)
- Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy (2005) (445)
- Alcohol consumption and hypertension. (1987) (417)
- Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease (1997) (382)
- Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. (2003) (382)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
- Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. (2001) (361)
- Diabetes and the risk of stroke. The Honolulu Heart Program. (1987) (358)
- The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. (1986) (356)
- The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. (1986) (354)
- 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
- EFFECT OF INTRAVENOUS NITRATES ON MORTALITY IN ACUTE MYOCARDIAL INFARCTION: AN OVERVIEW OF THE RANDOMISED TRIALS (1988) (329)
- Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease (1995) (328)
- The burden of blood pressure-related disease: a neglected priority for global health. (2007) (328)
- Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden (2006) (322)
- Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials (2001) (320)
- Risk prediction in patients with heart failure: a systematic review and analysis. (2014) (315)
- Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system (2007) (314)
- Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial (2006) (308)
- Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. (1988) (307)
- The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. (2003) (301)
- Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds (2012) (297)
- Blood pressure and risk of stroke in patients with cerebrovascular disease (1996) (276)
- Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
- Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial (2003) (253)
- Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
- Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis Results of the LIPID Atherosclerosis Substudy (1998) (247)
- Blood Pressure and Mortality Among Men With Prior Myocardial Infarction (1995) (245)
- Obesity and hypertension: epidemiological and clinical issues. (1987) (245)
- Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. (1997) (244)
- Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up (2002) (240)
- Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. (2000) (237)
- Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies (2001) (236)
- Management of raised blood pressure in New Zealand: a discussion document. (1993) (235)
- Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. (1999) (234)
- Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis (2014) (231)
- Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. (2008) (226)
- Estimation of Arterial Stiffness, Compliance, and Distensibility From M‐Mode Ultrasound Measurements of the Common Carotid Artery (1994) (210)
- Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials (2013) (203)
- The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials (2011) (203)
- Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial (2001) (200)
- Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials (1996) (197)
- Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. (1984) (190)
- Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial (2010) (188)
- Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2009) (187)
- The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. (1993) (186)
- Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
- Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. (2006) (184)
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
- Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
- The epidemiology of blood pressure and its worldwide management. (2015) (172)
- Pravastatin therapy and the risk of stroke. (2000) (170)
- Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis (2011) (166)
- Reducing the global burden of blood pressure-related cardiovascular disease. (2000) (165)
- The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
- Blood pressure, antihypertensive treatment and stroke risk. (1994) (160)
- Global inequalities in access to cardiovascular health care: our greatest challenge. (2008) (159)
- Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels (2006) (154)
- 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
- Alcohol consumption and the risk of alcohol related cirrhosis in women. (1987) (150)
- Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke (2008) (145)
- COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS (1985) (145)
- Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. (1997) (145)
- Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
- The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition (2003) (136)
- Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. (1997) (131)
- Plasma Lipoprotein Levels in Treated and Untreated Hypertensive Men and Women: The National Heart Foundation of Australia Risk Factor Prevalence Study (1985) (127)
- Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke (2005) (125)
- Incidence of heterotopic bone formation after major hip surgery (2002) (125)
- A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery (2000) (118)
- The effects of antihypertensive treatment on vascular disease: Reappraisal of the evidence in 1994 (1993) (117)
- B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. (1993) (116)
- Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies (2018) (115)
- Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. (1989) (113)
- Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. (1995) (111)
- Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease. (2001) (107)
- Hypertension: comparison of drug and non-drug treatments. (1982) (106)
- APOE genotype, ethnicity, and the risk of cerebral hemorrhage (2008) (105)
- Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. (2007) (104)
- Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History (2009) (102)
- High prevalence of chronic kidney disease in Thailand. (2008) (99)
- Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
- Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis (2012) (98)
- Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
- SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India (2014) (97)
- Blood pressure and the risk of cardiovascular disease. (2000) (96)
- Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
- Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. (1994) (95)
- International Society of Hypertension (ISH): Statement on Blood Pressure Lowering and Stroke Prevention (2003) (93)
- Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial (2015) (93)
- Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China. (2016) (90)
- Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2005) (89)
- Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial (2006) (83)
- Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study (2000) (83)
- Mitral valve prolapse and infective endocarditis. (1987) (83)
- Mitral valve prolapse and bacterial endocarditis: when is antibiotic prophylaxis necessary? (1984) (82)
- Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91. (1995) (82)
- Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
- Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease (2005) (81)
- Association of environmental tobacco smoke exposure with socioeconomic status in a population of 7725 New Zealanders. (1998) (81)
- Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary (2006) (80)
- Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. (1995) (79)
- The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. (2012) (78)
- Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare (2017) (77)
- Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial (2004) (76)
- Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
- Beta-blockers in heart failure: promising or proved? (1994) (73)
- Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India (2009) (71)
- A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease (2007) (71)
- Cardiovascular risk factor levels in urban and rural Thailand--The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). (2003) (69)
- Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries (2003) (69)
- Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial (2013) (68)
- Antihypertensive Drug Treatment Potential, Expected, and Observed Effects on Stroke and on Coronary Heart Disease (1989) (68)
- The Epidemiological Association between Blood Pressure and Stroke: Implications for Primary and Secondary Prevention (1994) (67)
- Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study. (1986) (67)
- International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. (2004) (66)
- Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial (2006) (66)
- ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline (2005) (66)
- Cholesterol and total mortality: need for larger trials. (1992) (65)
- Blood-pressure-related disease is a global health priority. (2008) (64)
- Risk of infective endocarditis in mitral valve prolapse with and without precordial systolic murmurs. (1987) (64)
- Systematic Underestimation of Treatment Effects as a Result of Diagnostic Test Inaccuracy: Implications for the Interpretation and Design of Thromboprophylaxis Trials (1995) (63)
- Effect of Intravenous Nitrates on Mortality in Acute Myocardial Infarction (1993) (63)
- The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
- Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
- Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
- Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group. (1995) (59)
- Obesity as a risk factor for COVID‐19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease (2020) (58)
- REDUCTION IN MAJOR MORBIDITY AND MORTALITY BY HEPARIN IN ACUTE MYOCARDIAL-INFARCTION (1989) (57)
- The world health organization—International society of hypertension blood pressure lowering treatment trialists’ collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments (1999) (56)
- Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults (2016) (56)
- Determinants of cardiovascualar disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies (1999) (56)
- Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke (2013) (55)
- The Effects of a Community-Based Sodium Reduction Program in Rural China – A Cluster-Randomized Trial (2016) (55)
- The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock. (2010) (53)
- Reliable assessment of the effects of treatments on mortality and major morbidity (2007) (52)
- Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings. (1995) (51)
- Hypertension—time to move on (2005) (51)
- Blood pressure and the prevention of stroke (1996) (50)
- Major clinical trials of hypertension: what should be done next? (2005) (50)
- Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region (2004) (49)
- Leg ulceration and perceived health: a population based case-control study. (2004) (49)
- Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial (2012) (49)
- Left ventricular mass correlates with fat-free mass but not fat mass in adults. (1999) (49)
- Mortality after hip fracture: regional variations in New Zealand. (1999) (48)
- Random errors in the measurement of 10 cardiovascular risk factors (2004) (47)
- The effects of diabetes mellitus on the risks of major cardiovascular diseases and death in the Asia-Pacific region (Journal article) (2003) (47)
- The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
- A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
- Motor vehicle driver injury and marital status: a cohort study with prospective and retrospective driver injuries (2004) (46)
- Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. (1986) (45)
- Chronic suppurative osteomyelitis of the mandible: case report. (2005) (45)
- Is body mass index a risk factor for motor vehicle driver injury? A cohort study with prospective and retrospective outcomes. (2003) (44)
- Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. (2005) (44)
- Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease (2005) (44)
- Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. (1997) (44)
- Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults (2018) (43)
- No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients (2000) (43)
- The Treatment of cardiovascular Risk in Primary care using Electronic Decision suppOrt (TORPEDO) study: intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare (2012) (42)
- Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. (2006) (41)
- Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. (2008) (40)
- Blood-pressure-related disease is a global health priority. (2008) (40)
- Blood pressure and coronary heart disease (1990) (40)
- Global burden of blood pressure-related disease (1999) (1999) (40)
- The global burden of hypertension (2001) (38)
- Effects of different blood pressure lowering regimens on major cardiovascular events: second cycle of prospectively designed overviews (2003) (38)
- Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group. (1997) (36)
- Alcohol and hypertension: implications for prevention and treatment. (1986) (36)
- Blood-pressure-related disease is a global health priority (2008) (36)
- SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India (2019) (35)
- The occurrence of leg ulcers in Auckland: results of a population-based study. (2002) (35)
- Verbal autopsy coding: are multiple coders better than one? (2009) (34)
- Socioeconomic distribution of smoking in a population of 10,529 New Zealanders. (1997) (34)
- Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial* (2011) (34)
- PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. (2000) (34)
- Leg ulcers in New Zealand: age at onset, recurrence and provision of care in an urban population. (2002) (34)
- Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. (2009) (33)
- Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial (2010) (33)
- Blood pressure and the global burden of cardiovascular disease. (1999) (32)
- The determinants of fat intake in a multi-ethnic New Zealand population. Fletcher Challenge--University of Auckland Heart and Health Study Management Committee. (1998) (30)
- A clinical trial of the effect of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. (1998) (30)
- Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease: A Randomized Controlled Trial (2003) (30)
- Differences between blood-pressure-lowering drugs (2000) (28)
- Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens: An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials (2010) (28)
- Risk Prediction in Patients With Heart Failure (27)
- The New Zealand Blood Donors' Health Study: baseline findings of a large prospective cohort study of injury (2002) (27)
- Collaborative overview (‘Meta-Analysis’) of Prospective Observational Studies of the Associations of Usual Blood Pressure and Usual Cholesterol Levels with Common Causes of Death: Protocol for the Second Cycle of the Prospective Studies Collaboration (1999) (26)
- Ethnic differences in blood pressure: findings from the Fletcher Challenge-Auckland University Heart and Health Study. (1996) (26)
- Regional variation in the incidence of hip fracture in New Zealand. (1997) (26)
- Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. (2002) (26)
- Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial. (1994) (25)
- Global burden of blood pressure-related disease (2001) (2001) (25)
- Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
- The lowering of blood pressure after stroke (2001) (24)
- Does capture‐recapture analysis provide more reliable estimates of the incidence and prevalence of leg ulcers in the community? (2002) (23)
- Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults (2017) (23)
- Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation (2003) (23)
- The PROGRESS study: Rationale and design (1995) (23)
- Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
- Atherosclerosis and left ventricular hypertrophy: persisting problems in treated hypertensive patients. (1998) (23)
- The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials (2017) (23)
- Primary and secondary prevention of stroke. (1996) (23)
- Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial (2014) (22)
- Prevention of cardiovascular diseases in developing countries: agenda for action (statement from a WHO-ISH Meeting in Beijing, October 1999). (2000) (22)
- Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group. (1997) (21)
- Blood Pressure Lowering for the Prevention of Cognitive Decline in Patients with Cerebrovascular Disease (1997) (21)
- Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial (2014) (20)
- Leg ulceration as a long-term complication of deep vein thrombosis. (2003) (20)
- An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1999) (19)
- Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. (1994) (19)
- Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy (1998) (19)
- CHRISTCHURCH CARDIOENDO-CRINE RESEARCH GROUP; AUSTRALIA-NEW ZEALAND HEART FAILURE GROUP. COMPARISON OF BT-YPE NATRIURETIC PEPTIDES FOR ASSESSMENT OF CARDIAC FUNCTION AND PROGNOSIS IN STABLE ISCHEMIC HEART DISEASE (2006) (18)
- BLOOD PRESSURE LOWERING IN PATIENTS WITH CEREBROVASCULAR DISEASE: RESULTS OF THE PROGRESS (PERINDOPRIL PROTECTION AGAINST RECURRENT STROKE STUDY) PILOT PHASE (1996) (18)
- Blood pressure and cardiovascular disease: tracing the steps from Framingham. (2010) (18)
- Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. (2015) (17)
- The effects of antihypertensive drug treatment on the incidence of stroke and of coronary heart disease. (1989) (17)
- IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
- Blood pressure management in the 21st century: maximizing gains and minimizing waste. (2013) (17)
- The J-Curve Phenomenon and the Treatment of Hypertension (1991) (17)
- Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region (2009) (16)
- Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. (2009) (16)
- Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS MRI Substudy (2005) (16)
- A RANDOMIZED CONTROLLED TRIAL OF WEIGHT REDUCTION AND METOPROLOL IN THE TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS (1985) (16)
- Attitudes and Practices of New Zealand Anaesthetists with Regard to Epidural and Subarachnoid Anaesthesia (1996) (15)
- The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
- Introduction: The global burden of stroke (2002) (15)
- Clinician's Manual on Blood Pressure and Stroke Prevention (2002) (15)
- Pravastatin Reduces Total Mortality in Patients With Coronary Heart Disease and Average Cholesterol Levels: Relationship of Baseline Cholesterol and Treatment Effects in the LIPID Trial (1998) (15)
- The associations of diastolic blood pressure with the risk of stroke in Western and Eastern populations. (1999) (14)
- Does interleukin-18 or tumour necrosis factor-alpha have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand. (2010) (14)
- Blood pressure reduction and the prevention of stroke (1991) (14)
- Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India (2018) (14)
- Treatment of high blood pressure in overweight patients. (1987) (14)
- The PROGRESS trial three years later: time for more action, less distraction (2004) (14)
- A user-centred home monitoring and self-management system for patients with heart failure: a multicentre cohort study. (2015) (14)
- Migraine: a risk factor for motor vehicle driver injury? (1997) (14)
- Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. (2000) (14)
- Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration. (1999) (14)
- Blood pressure lowering with fixed combination perindopril–indapamide: key findings from ADVANCE (2008) (13)
- Industry-sponsored clinical trials in emerging markets: time to review the terms of engagement. (2013) (13)
- 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
- Intensive glucose control in type 2 diabetes – Reply (2008) (13)
- M-mode echocardiography: reproducibility of serial left ventricular measurements in subjects with normal ventricles and patients with congestive cardiomyopathy. (1983) (13)
- Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning? (2012) (13)
- Regional anaesthesia reduces perioperative mortality: results from an overview of randomised trials (2000) (12)
- Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease. (1995) (12)
- Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With Mortality (2019) (12)
- Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors (1997) (12)
- Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program (2017) (11)
- Prevention of cardiovascular diseases in developing countries: agenda for action: statement from a WHO-ISH meeting in Beijing (1999) (11)
- The HRT furore: getting the message right (2002) (11)
- Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA (130th American Neurological Association) (2005) (11)
- An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event (2009) (10)
- Study protocol: systematic review of the burden of heart failure in low- and middle-income countries (2012) (10)
- A prospective cohort study of blood donors: methodological issues in the investigation of injuries and chronic diseases (1998) (10)
- Use of major surgery in south India: A retrospective audit of hospital claim data from a large, community health insurance program. (2015) (10)
- LightWeight IP Application Examples (2014) (9)
- Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. (2003) (9)
- Selection bias in clinical research when subjects are excluded because of failure to estimate left ventricular mass by echocardiography. (1998) (9)
- Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease (2007) (9)
- Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. (1998) (9)
- PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected]. (1995) (9)
- The global burden of blood pressure-related diseases (1999) (9)
- Blood pressure levels and mortality from cerebrovascular disease in Australia and the United States. (1984) (8)
- Blood pressure and the burden of coronary heart disease (2009) (8)
- WEIGHT REDUCTION IN HYPERTENSION (1985) (8)
- Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease (2007) (8)
- Effects of Lidocaine on Ventricular Fibrillation, Asystole, and Early Death in Patients with Suspected Acute Myocardial Infarction (1987) (8)
- Forty years of randomised trials in the New Zealand Medical Journal. (1996) (8)
- China Rural Health Initiative – Sodium Reduction Study: the effect of a community-based sodium reduction program on 24hr urinary sodium and blood pressure in rural China (2013) (7)
- HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION (1992) (7)
- Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusNovelty and Significance (2015) (7)
- Epidemiology and prevention of cardiovascular disease (2005) (7)
- PROGRESS – perindopril protection against recurrent stroke study: status in July 1996 (1996) (7)
- The burden of blood pressure related disease (2002) (7)
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
- Antihypertensive Agents and Stroke Prevention (1994) (6)
- Compression of Pulmonary Veins Between the Left Atrium and the Descending Aorta (2003) (6)
- Blood Pressure Lowering In Diabetes: A Brief Review Of The Current Evidence And Description Of A New Trial (2001) (6)
- ADVANTAGES AND DISADVANTAGES OF THE META-ANALYSIS APPROACH. DISCUSSION (1996) (5)
- Cholestrol, coronary heart disease, and stroke in the Asia Pacific region (2007) (2007) (5)
- The ADVANCE trial – Authors' reply (2008) (5)
- Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study. (1997) (5)
- Future Directions for Randomized Trials of Cardiovascular Disease Prevention in Hypertensive Patients (1990) (5)
- Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial (2021) (5)
- Epidemiological research in cardiovascular disease in Australia: 1984. (1985) (5)
- Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial (2008) (4)
- High prevalence of chronic kidney disease in (2008) (4)
- Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
- Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme (2015) (4)
- The Saline vs. Albumin Fluid Evaluation (SAFE) Study (2018) (4)
- PEP trial - Reply (2000) (4)
- Global epidemiology of cardiovascular disease (2000) (4)
- Blood pressure and the risk of recurrent vascular disease (1998) (3)
- Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III (2008) (3)
- Antiplatelet therapy and the prevention of thrombosis. (1996) (3)
- Pravastatin therapy and the risk of stroke: results from the LIPID study (2000) (3)
- surgery (HIPAID): randomised controlled trial ectopic bone formation after hip replacement ibuprofen for pain and disability related to Safety and efficacy of routine postoperative (2008) (3)
- Responding to China's hypertensive crisis (2009) (2)
- Management of raised blood pressure. (1994) (2)
- Prevalence of hypertension in CHD patients in the asia-pacific region: the aspac study (2000) (2)
- The predictive ability of different measures of kidney function: new data from the Progress study (2006) (2)
- Lowering Cholesterol Levels in Patients with Coronary Heart-Disease - the 4s Trial Showed That Lowering High Cholesterol Levels Improves Survival in Patients with Coronary Heart-Disease - Do the Benefits Extend to Those with Average Cholesterol Levels (1995) (2)
- 06 The pulmonary embolism prevention (PEP) trial: effects of low-dose aspirin on major vascular events in hip fracture surgical patients (1999) (2)
- Progress: Perindopril protection against recurrent stroke study: rationale, results and importance: perspective from the principle investigators (2003) (2)
- Atherosclerosis and Left Ventricular Hypertrophy: Persisting Problems in Treated Hypertensive Patients (1998) (2)
- Evidence from randomised controlled trials of antihypertensive drugs (1999) (2)
- Prevention of cardiovascular morbidity and mortality in hypertension: benefits of blood pressure reduction and cholesterol lowering. (1989) (2)
- THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
- Cholesterol and total mortality (1992) (2)
- New approaches for the prevention of vascular disease in Type 2 diabetes (2008) (1)
- Perindopril protection against recurrent stroke study (PROGRESS) (2001) (1)
- Carvedilol reduces left ventricular volumes in patients with heart failure of ischemic etiology (1996) (1)
- Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease (2006) (1)
- The Apolipoprotein E genotype and the risk of cerebral hemorrhage in stroke patients of Asian origin (2006) (1)
- Abstract 204: Blood Pressure Reduction And Stroke Recurrence: The Progress Trial (2013) (1)
- Beyond hypertension - the burden of blood pressure related disease (2002) (1)
- Hypertension and cardiovascular disease (2000) (1)
- Cuts to the NHMRC budget will undermine the health of all Australians — today and in the future (2011) (1)
- Non-drug treatments of hypertension (1982) (1)
- China Rural Health Initiative – Primary care provider study: A large cluster-randomized controlled trial of high cardiovascular risk management in rural China (2013) (1)
- THE RELATIONS OF SERUM-CHOLESTEROL, BLOOD-PRESSURE, AND SMOKING HABIT TO CORONARY HEART-DISEASE IN A POPULATION WITH LOW MEAN CONCENTRATIONS OF SERUM-CHOLESTEROL (1989) (1)
- New paradigm in hypertension management [Invited lecture] (2004) (1)
- The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture (1999) (1)
- The effects of body mass and alcohol consumption on blood pressure levels and the prevalence of hypertension in Australian men and women (1984) (1)
- The critical examination of x-ray generating equipment in diagnostic radiology. (Guidance on the interpretation of the ionising radiations regulations 1985, regulation 32(2) a). (IPEM Report 79) (1999) (1)
- Patient Preference for Ketamine: A Case Report of Multiple Anesthesias (1975) (1)
- Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons (2005) (1)
- PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke (2021) (1)
- PROGRESS in the treatment of stroke (2001) (1)
- Polypills for the prevention of cardiovascular disease: a framework for wider use (2022) (1)
- Lacunar stroke in PROGRESS study (2004) (1)
- Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress (2022) (1)
- Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial (2012) (1)
- Methodological aspects: general discussion (1996) (1)
- Blood pressure drugs cut death rate in diabetes (2007) (0)
- Patterns and trends in motor vehicle related injury death rates in China: 1987-1997 (1999) (0)
- Plenary lecture. ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes. Hotline session (2007) (0)
- Cardiovascular risk in Asia: an overview [Invited lecture] (2007) (0)
- Role of observational epidemiology in clinical trials (2005) (0)
- The global burden of cardiovascular disease. Satellite Symposium: Modern approaches to protect target organs in patients at increased total cardiovascular risk [Invited lecture] (2006) (0)
- Perindopril-based blood pressure lowering reduces major vascular and bleeding events in patients with cerebrovascular disease who use antithrombotic therapy: the PROGRESS trial (2011) (0)
- The true effects of established risk factors of cardiovascular disease (1999) (0)
- Lower blood pressure and the risk of recurrent stroke in patients with chronic kidney disease: results of the PROGRESS trial (2008) (0)
- Faculty Opinions recommendation of Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. (2008) (0)
- Global inequalities in cardiovascular healthcare: our greatest challenge (2007) (0)
- Results of the second cycle of the Blood Pressure Lowering Treatment Trialists’ Collaboration (2003) (0)
- Blood pressure, blood cholesterol, smoking. Disease control priorities in developing countries 2: Consultation of cardiovascular diseases. What do we know and what do we need to know for control CVD in developing countries? (2002) (0)
- Author response for "Obesity as a risk factor for COVID ‐19 mortality in women and men in the UK Biobank: comparisons with influenza/pneumonia and coronary heart disease" (2020) (0)
- Blood pressure and cardiovascular disease in the Asia Pacific region (2007) (2007) (0)
- Treatment for high blood pressure: evidence and practice. (1998) (0)
- [Keynote speaker] The role of academic health centers in developing global health priorities. John P. McGovern Award Lecture. (2010) (0)
- [Letter to the Editor] ADVANCE Blood pressure lowering in diabetes (2009) (0)
- Effects of calcium antagonists on CHD, CHF and stroke [Invited lecture] (2006) (0)
- Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial (2012) (0)
- Preventing cardiovascular events in diabetic patients: the ADVANCE study. Satellite Symposium (2007) (0)
- PROGRESS main results. Satellite symposium "PROGRESS in Stroke Prevention" (2001) (0)
- Results of recent trials of anti-hypertensive drugs.ALLHAT investigators meeting (2000) (0)
- Invited lecture on Role of fixed dose combination in clinical practice: 3 perspectives (2005) (0)
- Do men and women respond differently to blood pressure lowering treatment? prospective meta-analysis of randomised trials (2008) (0)
- Blood pressure and vascular disease: a global perspective (2008) (0)
- Health-related aspects of lifestyle in general hospital patients. (2010) (0)
- [Keynote lecture - Plenary Session] Clinical Trials: interpretation (2008) (0)
- POST HOC ANALYSIS : USE AND DANGERS IN PERSPECTIVE. DISCUSSION (1996) (0)
- Effects of ACE inhibitors on athersclerosis - final results from the PART 2 trial (1999) (0)
- Implications for chronic disease management in the Asia Pacific region. The Bangkok challenge: from conflict to cooperation and beyond [Invited lecture] (2007) (0)
- Epidemiological Outlook. Cardiovascular Risk Management: Bayer’s Expertise in a Complex Area (2005) (0)
- ADVANCE: Blood Pressure Lowering in Diabetes (Letter to the Editor) (2009) (0)
- Serum triglycerides and coronary heart disease in Asia Pacific populations (2003) (0)
- Connectiviety of CV risk factors: do we have enough epidemiological evidence [Invited lecture] (2005) (0)
- Higher total serum cholesterol is associated with greater risk of coronary heart disease and ischemic stroke, but not haemorrhagic stroke: Evidence from the Asia Pacific Cohort studies collaboration (2002) (0)
- Systolic pressure and pulse pressure as determinants of cardiovascular disease (1999) (0)
- Epidemiology of BP related diseases in Asia and Australasia (2001) (0)
- Renal outcome and microalbuminuria data from ADVANCE (2008) (0)
- Blood pressure control for the prevention of cardiovascular disease in developing countries (1999) (0)
- Experiences of Chronic Disease Prevention and Control during Social Transition (2011) (0)
- Opportunities and chanllenges for conducting clinical trials outside the US and Western Europe - pathways and markets [Invited lecture] (2006) (0)
- [Keynote speaker] Pragmatic trials: a bold new paradigm for sepsis research (2010) (0)
- Effects of Antihypertensive Treatment on Coronary Artery Disease: Directions for Future Research (1991) (0)
- Lowering Blood pressure in the non-diabetic: How far and with what? Advances in Diabetes, Vascular Disease and the Kidney [Invited speaker] (2010) (0)
- National Heart Foundation Visiting Lecturer: The prevention of heart disease – So much achieved for so few (2011) (0)
- The efficacy of lower blood pressure goals on the prevention of stroke in chronic kidney disease: data from the PROGRESS study (2007) (0)
- The importance of co-existing CV risk factors (2006) (0)
- Abstract 12563: Variation in Referral for Specialist Follow-Up and 30-Day Mortality in Patients Hospitalized With Heart Failure in England and Wales (2014) (0)
- Vascular protective effects of ACE inhibitator-based blood pressure lowering-PROGRESS results. From hypertension to stroke - what is the connection? (2001) (0)
- COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY (2007) (0)
- The importance of co-existing cardiovascular risk factors. Preventive Cardiology Sympsoium [Invited lecture] (2006) (0)
- Reduction in coronary events with pravastatin and proportion of treatment benefit explained by on-study LIPID levels in the LIPID study (2000) (0)
- VALUE in the context of other recent trials of blood pressure lowering [Invited lecture] (2004) (0)
- Smoking status and the risk of fatal coronary heart disease in Asian and Australisian populations (2003) (0)
- retrospective driver injuries status: a cohort study with prospective and Motor vehicle driver injury and socioeconomic (2005) (0)
- Worldwide epidemiologic data: coexistence of multiple risk factors (2006) (0)
- Blood Pressure Trialists' Collaboration: Second cycle of overviews. Global Chapter Meeting of the Vascular Biology Working Group [Invited lecture] (2003) (0)
- New frontiers in cardiovascular risk management: optimizing outcomes in patients with cardiovascular risks [Invited lecture] (2006) (0)
- Results of the Pulmonary Embolism Prevention Trial (1999) (0)
- Initiative for Cardiovascular Health Research in Developing Countries (IC Health) (Conference Paper) (2003) (0)
- Preventing the growing burden of stroke (2002) (0)
- Lowering Blood Pressure in Patients with Type 2 Diabetes Significantly Reduces the Risk of Death from Diabetic Complications Even in Patients with Normal Blood Pressure (2007) (0)
- COST-EFFECTIVENESS CALCULATIONS FROM TRIALS. DISUCUSSION (1996) (0)
- Overview of trials completed or in progress: what's resolved and what's not? (1996) (0)
- ADVANCE: Blood Pressure Lowering in Diabetes (2009) (0)
- Blood pressure lowering therapy (2002) (0)
- Clinical drug development in Asia: challenges and opportunities [Invited lecture] (2007) (0)
- Blood pressure and vascular disease: From observational studies to randomised trials and beyond (2008) (0)
- CHINESE CONTRIBUTION TO TRIALS ON ANTIHYPERTENSIVE THERAPY. DISCUSSION (1996) (0)
- Blood Pressure Lowering Treatment Trialists’ Collaboration: second cycle of overviews (2003) (0)
- From Telemedicine to Wearables: The Impact of Technological Innovations on Global Health. Topic: Systematic Medical Appraisal, Referral and Treatment for NCDs (2016) (0)
- Outcome trials in hypertension - implications for practice [Invited lecture] (2005) (0)
- Hypertension trials - past, present and future (2000) (0)
- Practical lessons from hypertension programmes on the Indian Sub Continent and China (2011) (0)
- Effects of omatpatrilat on blood pressure and neurohormone levels among 723 individuals with CHD - the PACIFIC study (2001) (0)
- Clinical Trials in Hypertension and Congestive Heart Failure (1986) (0)
- Invited lecture. A framework for conducting trials with greater clinical relevance. designing clinical trials to change practice in thrombosis management sessions (2005) (0)
- New perspectives in cardiovascular disease and its treatment (2002) (0)
- ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
- [OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION (2017) (0)
- Cost effective strategies for cardiovascular risk reduction — workshop (2003) (0)
- METHODOLOGICAL ASPECTS : GENERAL DISCUSSION. DISCUSSION (1996) (0)
- Renal and microalbuminuria data from ADVANCE (2009) (0)
- “Frugal” healthcare innovation – a global research priority (2012) (0)
- 68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2012) (0)
- Women as participants in cardiovascular trials (1986) (0)
- Clinical trials, observational studies and the media (2002) (0)
- Frugal innovation - The future of cardiovascular medicine (2012) (0)
- Is there evidence ot support differences in outcome claims for different antihypertensive drug classes (2005) (0)
- Cardiovascular disease in Asia - the present and the future [Invited lecture] (2006) (0)
- P4932Elevated blood pressure and risk of mitral regurgitation (2017) (0)
- Plenary lecture. Blood Pressure Trialists' Collaboration: results of the second cycle of analyses (2004) (0)
- New insights from the blood pressure Lowering Treatment Trialists' Collaboration [Invited lecture] (2006) (0)
- 3.1 Stroke, coronary heart disease, cholesterol and blood pressure (1997) (0)
- PEP trial (2000) (0)
- Reductions in the risk of vascular events and stroke in patients with and without chronic kidney disease; new data from the PROGRESS trial (2006) (0)
- Blood pressure lowering for the prevention of vascular complications of non-insulin dependent diabetes mellitus (2000) (0)
- The newest WHO-ISH meta-analysis and VALUE trial: The importance of lowering blood pressure in preventing cardiovascular events [Invited lecture] (2004) (0)
- Cardiovascular disease: a neglected yet avoidable threat to develpment and the alleviation of poverty [Invited lecture] (2004) (0)
- Population trends in cardiovascular risk factors: new insights [Invited lecture] (2005) (0)
- Blood pressure and secondary prevention of stroke (1999) (0)
- Treatment of hypertensive patients is more than blood-pressure control (2003) (0)
- Revaluation of the effects of rennin-angiotensin system inhibitors : new results from the BPLTTC (2006) (0)
- Outcome trials - completing the picture [Invited lecture] (2006) (0)
- The occurence of leg ulcers in Auckland: Results of a population of a population-based study (2002) (0)
- Conventional risk factors: evolving concepts of risk and expanding strategies for prevention (2000) (0)
- Medical treatment for hypertension: evidence from clinical trials. ISH satellite symposium (2000) (0)
- Can NT-proBNP monitoring help prevent cardiovascular disease? Recent Advances in Cardiovascular Disease (2007) (0)
- Stroke prevention - the role of blood pressure lowering [Invited lecture] (2006) (0)
- Global burden of cardiovascular disease. National Heart Foundation Lecture (1999) (0)
- BLOOD PRESSURE LOWERING FOR THE SECONDARY PREVENTION OF STROKE : RATIONALEAND DESIGN FOR PROGRESS. DISCUSSION (1996) (0)
- A major step forward in stroke prevention: therapeutic implications of the PROGRESS trial (2001) (0)
- Effects of antihypertensive treatment on outcome: a meta-analysis (2001) (0)
- Global Healthcare: Innovative Affordable Strategies for Health (2011) (0)
- The importance of blood pressure reduction: evidence from epidemiological studies and clinical trials (2003) (0)
- Determinants of Atherosclerosis in Hypertensives (1998) (0)
- [PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
- Our Greatest Challenge (0)
- Blood Pressure Trialists' Collaboration: secnond cycle of overviews [Invited lecture] (2003) (0)
- Sustainable healthcare for the 21st century. (2013) (0)
- World Health Organisation-International Society of Hypertension Blood Lowering Treatment Trialists' Collaboration (2000) (0)
- Risk-based prevention programmes for primary care: what evidence do we need? (2011) (0)
- PROGRESS - from blood pressue lowering to prevention of stroke (2001) (0)
- Blood pressure and cardiovascular disease in the Asia Pacific region (Chinese Journal of Cardiology) (2006) (0)
- Faculty Opinions recommendation of Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. (2009) (0)
- EDITORIAL Measuring Mäori health status accurately - more needs doing Tony Blakely, (2002) (0)
- Author Index / Subject Index Vol. 4 (suppl 1) 1994 (1994) (0)
- Facts and fallacies in the history of antihypertensive treatment. Calcuim antagonist story (2005) (0)
- Keynote lecture. The global impact of the cardiovascular disease epidemic (2006) (0)
- Non communicable diseases: the challenges for developing countries (2000) (0)
- 707-2 Effects of Carvedilol on Left Ventricular Function and Exercise Performance in Patients with Heart Failure of Ischemic Etiology (1995) (0)
- Debate: the results of surrogate endpoint trials should influence clinical practice (against the motion). Preventive cardiolgoy - principles and practice (2000) (0)
- Blood Pressure as Risk Factor for Several Diseases Blood Pressure and Cardiovascular Disease (2015) (0)
- Chapter 9: Renal and microalbuminuria data from ADVANCE (2009) (0)
- Clinical implications of PROGRESS: questions and answers (2003) (0)
- Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
- Burden of cardiovascular diseases and diabetes (2003) (0)
- Is there greater VALUE of lowering BP or medication choice? Integrating Lipid and BP management into a New Paradigm for Intensive Cardiovascular Prevention [Invited lecture] (2004) (0)
- Preventing cardiovascular events in diabetic patients: the ADVANCE study [Invited lecture] (2007) (0)
- Epidemiological aspects of hypertension and dyslipidaemia. burden of hypertension and dyslipidaemia in cardiovascualr disease [Satellite Symposium: Invited lecture] (2004) (0)
- Satellite Symposium: Invited lecture on A multifactorial approach to treatment - what do the meta-analyses tell us? Maning multiple risk factors in cardiovascular disease: new insights and future directions (2004) (0)
- Differences in outcome claims for different drug classes (2005) (0)
- General claims for anti-hypertension drugs (2005) (0)
- PATIENT PREFERENCE FOR KETAMINE (1975) (0)
- WHO-ISH Blood Pressure Lowering Treatment Trialists' Collaboration: main results from first cycle of analyses (2000) (0)
- Subject Index, Vol. 47, 1987 (1987) (0)
- Blood pressure targets in the hypertensive patient symposium (2001) (0)
- PROGRESS main results. Symposium on Seconday Stroke Prevention (2001) (0)
- Hypertension – time to give it up? (2008) (0)
- The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials. (2022) (0)
- Blood pressure and vascular complications of diabetes (2001) (0)
- New evidence from trials of blood pressure lowering - implications for patient care (2006) (0)
- Results of principal endpoint studies, ongoing studies and expected future results (2002) (0)
- ROUTINE PERIOPERATIVE NSAIDS PROPHYLAXIS FOR ECTOPIC BONE FORMATION AFTER HIP REPLACEMENT SURGERY (HIPAID). A RANDOMISED CLINICAL TRIAL (2009) (0)
- Prolonged and sustained reduction in total and coronary mortality in patients assigned pravastatin in the LIPID trial during two further years of follow-up (2000) (0)
- Blood pressure management in the 21st century: maximising the gains, minimising the waste (2013) (0)
- Blood pressure, ischaemic stroke and myocardial infarction (2000) (0)
- Blood-pressure-lowering meta-analysis revisited: placing VALUE and other new trials in perspective [Invited lecture] (2004) (0)
- Cardiovascular diseases in Asia and the Pacific - causes and consquences (2001) (0)
- O3-04-08 Effect of white matter lesions on incidence of dementia in patients with stroke (2006) (0)
- Designer drugs for the doctor to Asia'a poor ; Polio, TB, tropical disease give way to diabetes, stroke, road trauma . . . (2013) (0)
- Pregnancy and leg ulceration. (2004) (0)
- Targeting total CV risk in clinical practice. Satellite symposium (2007) (0)
- ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes (2007) (0)
- Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 11 Medica (2018) (0)
- Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
- Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
- Bloodpressure andriskof stroke inpatients with cerebrovascular disease (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stephen W. Macmahon?
Stephen W. Macmahon is affiliated with the following schools: